| Dr Spencer Joel Markowitz, MD | |
|
300 N Main St Ste D, Crown Point, IN 46307-3281 | |
| (219) 663-4888 | |
| (219) 663-4877 |
| Full Name | Dr Spencer Joel Markowitz |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 30 Years |
| Location | 300 N Main St Ste D, Crown Point, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265576524 | NPI | - | NPPES |
| 200149720 | Medicaid | IN | |
| IN2007007 | Other | IN | MEDICARE PTAN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 01046970A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Franciscan Health Crown Point | Crown point, IN | Hospital |
| Methodist Hospitals Inc | Gary, IN | Hospital |
| Aperion Care Demotte | Demotte, IN | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Aceso Visiting Physicians And Geriatric Care Inc. | 9133344708 | 12 |
News Archive
The American Geriatrics Society today offered a ringing endorsement of the bipartisan Geriatrics Workforce Improvement Act, a proposal in the U.S. Senate to ensure communities across the U.S. have access to health professionals and other critical supports improving care for us all as we age.
Omeros Corporation today announced that the U.S. Food and Drug Administration granted Fast Track designation to OMS721 for the treatment of patients with atypical hemolytic uremic syndrome (aHUS). OMS721 is the company's lead human monoclonal antibody targeting mannan-binding lectin-associated serine protease-2 (MASP-2), the key regulator of the lectin pathway of the immune system.
Holiday celebrations often revolve around eating, but for those with food restrictions, that can produce an incongruous feeling when dining with friends and loved ones: loneliness.
PolyMedix, Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat acute cardiovascular disorders and infectious diseases, has received a Phase 2 grant in the amount of $986,000 from the National Institute of Health (NIH) to support the development of defensin mimetic antimicrobial compounds for the treatment of oral candidiasis. This grant will fund this research project through August 31, 2012. This award represents the 14th grant or research contract received to date by PolyMedix.
The human heart is like a sponge, able to expand and grow, increasing its capacity to take up blood. In theory, an enlarged heart can also squeeze out more blood, with more power, than an average-sized heart. But in reality, for most people, this growth - known as cardiac hypertrophy - is abnormal and signals trouble.
› Verified 1 days ago
| Entity Name | Aceso Visiting Physicians And Geriatric Care Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982010690 PECOS PAC ID: 9133344708 Enrollment ID: O20140716000095 |
News Archive
The American Geriatrics Society today offered a ringing endorsement of the bipartisan Geriatrics Workforce Improvement Act, a proposal in the U.S. Senate to ensure communities across the U.S. have access to health professionals and other critical supports improving care for us all as we age.
Omeros Corporation today announced that the U.S. Food and Drug Administration granted Fast Track designation to OMS721 for the treatment of patients with atypical hemolytic uremic syndrome (aHUS). OMS721 is the company's lead human monoclonal antibody targeting mannan-binding lectin-associated serine protease-2 (MASP-2), the key regulator of the lectin pathway of the immune system.
Holiday celebrations often revolve around eating, but for those with food restrictions, that can produce an incongruous feeling when dining with friends and loved ones: loneliness.
PolyMedix, Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat acute cardiovascular disorders and infectious diseases, has received a Phase 2 grant in the amount of $986,000 from the National Institute of Health (NIH) to support the development of defensin mimetic antimicrobial compounds for the treatment of oral candidiasis. This grant will fund this research project through August 31, 2012. This award represents the 14th grant or research contract received to date by PolyMedix.
The human heart is like a sponge, able to expand and grow, increasing its capacity to take up blood. In theory, an enlarged heart can also squeeze out more blood, with more power, than an average-sized heart. But in reality, for most people, this growth - known as cardiac hypertrophy - is abnormal and signals trouble.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Spencer Joel Markowitz, MD 300 N Main St Ste D, Crown Point, IN 46307-3281 Ph: (219) 663-4888 | Dr Spencer Joel Markowitz, MD 300 N Main St Ste D, Crown Point, IN 46307-3281 Ph: (219) 663-4888 |
News Archive
The American Geriatrics Society today offered a ringing endorsement of the bipartisan Geriatrics Workforce Improvement Act, a proposal in the U.S. Senate to ensure communities across the U.S. have access to health professionals and other critical supports improving care for us all as we age.
Omeros Corporation today announced that the U.S. Food and Drug Administration granted Fast Track designation to OMS721 for the treatment of patients with atypical hemolytic uremic syndrome (aHUS). OMS721 is the company's lead human monoclonal antibody targeting mannan-binding lectin-associated serine protease-2 (MASP-2), the key regulator of the lectin pathway of the immune system.
Holiday celebrations often revolve around eating, but for those with food restrictions, that can produce an incongruous feeling when dining with friends and loved ones: loneliness.
PolyMedix, Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat acute cardiovascular disorders and infectious diseases, has received a Phase 2 grant in the amount of $986,000 from the National Institute of Health (NIH) to support the development of defensin mimetic antimicrobial compounds for the treatment of oral candidiasis. This grant will fund this research project through August 31, 2012. This award represents the 14th grant or research contract received to date by PolyMedix.
The human heart is like a sponge, able to expand and grow, increasing its capacity to take up blood. In theory, an enlarged heart can also squeeze out more blood, with more power, than an average-sized heart. But in reality, for most people, this growth - known as cardiac hypertrophy - is abnormal and signals trouble.
› Verified 1 days ago
Mr. Peter K Tothy, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 342 E 109th Ave, Crown Point, IN 46307 Phone: 219-310-2550 Fax: 219-310-2565 | |
Dr. Rani John Puthenveetil, M.D Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 9330 Broadway, Crown Point, IN 46307 Phone: 219-662-5000 | |
Boris Sagalovsky, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 12750 St Francis Dr Ste 320, Crown Point, IN 46307 Phone: 219-662-0077 Fax: 219-662-9496 | |
Sampanta Boonjarern, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 297 Franciscan Dr, Crown Point, IN 46307 Phone: 219-622-1718 | |
Mohamed Farhat, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1205 S Main St, Suite 301, Crown Point, IN 46307 Phone: 219-661-1640 Fax: 219-661-8066 | |
Dr. Arnolfo B Elman, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 1201 S Main St, Crown Point, IN 46307 Phone: 219-738-2100 Fax: 219-681-6867 | |
Arnold Michael Kemp, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 12750 St Francis Dr, Crown Point, IN 46307 Phone: 219-757-6121 Fax: 219-681-6897 |